Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SMOC2 encodes a member of the SPARC family (secreted protein acidic and rich in cysteine/osteonectin/BM-40), which are highly expressed during embryogenesis and wound healing.
Showing 10 out of 33 products:
Smoc2 modulates embryonic myelopoiesis during zebrafish development.
SMOC2 was highly expressed in both peritoneal and endometrioma lesions. Considering that the genes studied participate either directly or indirectly in cellular processes that can lead to cell migration, angiogenesis, and inappropriate invasion, it is possible that the deregulation of these genes caused the development and maintenance of ectopic tissue.
The expression of Smoc2 was significantly higher in hepatocellular carcinoma (HCC (show FAM126A Antibodies)) tissues compared with corresponding non-tumor liver tissues. Smoc2 promotes the proliferation of HCC (show FAM126A Antibodies) cells through accelerating cell cycle progression.
L1-mediated CRC (show CALR Antibodies) progression involves the acquisition of a stem cell-like phenotype, and that SMOC-2 elevation is necessary for L1-mediated induction of more aggressive/invasive CRC (show CALR Antibodies) properties.
could not detect an association between SMOC2 gene and AMD (show AMD1 Antibodies). This study tests the candidacy of SMOC2 gene to the etiology of AMD (show AMD1 Antibodies)
SMOC2 SNP may play a role in autoimmune thyroid disease susceptibility as a dominant polymorphism.
mutation in exon 8 of the SMOC2 gene linked to oligodontia
Homozygosity mapping and candidate prioritization identify mutations, missed by whole-exome sequencing, in SMOC2, causing major dental developmental defects
The variant rs13208776 in SMOC2 gene does not play a major role in increasing the risk of vitiligo (show MITF Antibodies) in Jordanian Arab patients.
SMOC2 is a risk locus for generalized vitiligo (show MITF Antibodies) and perhaps other autoimmune diseases
SMOC-2 is a novel angiogenic factor (show VEGFA Antibodies) that potentiates angiogenic effects of growth factors
SMOC1 (show SMOC1 Antibodies) and SMOC2 may mediate intercellular signaling and cell type-specific differentiation during gonad and reproductive tract development
SMOC-2 contributes to cell cycle progression by maintaining ILK (show ILK Antibodies) activity during G1.
SMOC-2, like other members of the BM40/SPARC (show SPARC Antibodies) family, acts as a regulator of cell-matrix interactions.
results indicate that Smoc2 is a novel transcriptional target of activated Ahr (show AHR Antibodies). Perturbation of Smoc2 expression may mediate the adverse developmental effects of environmental aryl-hydrocarbon exposure
This gene encodes a member of the SPARC family (secreted protein acidic and rich in cysteine/osteonectin/BM-40), which are highly expressed during embryogenesis and wound healing. The gene product is a matricellular protein which promotes matrix assembly and can stimulate endothelial cell proliferation and migration, as well as angiogenic activity. Associated with pulmonary function, this secretory gene product contains a Kazal domain, two thymoglobulin type-1 domains, and two EF-hand calcium-binding domains. The encoded protein may serve as a target for controlling angiogenesis in tumor growth and myocardial ischemia. Alternative splicing results in multiple transcript variants.
SPARC-related modular calcium-binding protein 2
, secreted modular calcium-binding protein 2
, SPARC related modular calcium binding 2
, SPARC-related modular calcium-binding protein 2-like
, smooth muscle associated protein 2
, smooth muscle-associated protein 2
, thyroglobulin type-1 repeat containing protein